United States securities and exchange commission logo





                             February 14, 2022

       Charles Wesley
       Chief Financial Officer
       Kolaboration Ventures Corporation
       183 Main Street
       Rio Vista, California 94571

                                                        Re: Kolaboration
Ventures Corporation
                                                            Offering Statement
on Form 1-A
                                                            Filed January 31,
2022
                                                            File No. 024-11791

       Dear Mr. Wesley:

              We have reviewed your offering statement and have the following
comments. In some of
       our comments, we may ask you to provide us with information so we may
better understand your
       disclosure.

              Please respond to this letter by amending your offering statement
and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response. After reviewing any amendment to your offering statement and
the information you
       provide in response to these comments, we may have additional comments.

       Offering Statement on Form 1-A

       Management's Discussion and Analysis of Kolaboration Ventures
Corporation, page 51

   1.                                                   Regarding your
Reorganization / Roll-up Transaction that became effective on October 1,
                                                        2021, explain to us, in
reasonable detail, how you considered providing pro forma
                                                        financial information
in your filing reflecting this transaction pursuant to Article 11 of
                                                        Regulation S-X, which
requires pro forma financial information when events occur for
                                                        which disclosure of pro
forma financial information would be material to investors.
                                                        Please refer to Part
F/S of Form 1-A and Sections 3140 and 3160 of the Division of
                                                        Corporate Finance
Financial Reporting Manual (   FRM   ) that include guidance and
                                                        an illustrative list of
events that could trigger reporting of pro forma financial
                                                        information. Please
revise to include pro forma financial statements and financial
                                                        information as
appropriate. In doing so, please disclose pro forma adjustments that give
                                                        effect to the different
cost structure and tax treatment applicable to the Corporation from
                                                        those applicable to the
predecessor entity, an LLC, or tell us why such presentation and
 Charles Wesley
FirstName LastNameCharles  Wesley
Kolaboration Ventures Corporation
Comapany14,
February   NameKolaboration
             2022            Ventures Corporation
February
Page 2 14, 2022 Page 2
FirstName LastName
         disclosures are not applicable. Please revise your MD&A disclosures to
quantify and
         discuss the expected change in your tax and cost structure subsequent
to the Roll-up
         Transaction.
2.       Regarding the Pacific Reserve Acquisition discussed on page 48,
provide us with your
         analysis to determine whether this acquisition is considered probable
and therefore,
         historical financial statements or pro forma financial statements
should be included in
         your filing. Refer to Rules 3-05, 8-04, 8-05 and Article 11 of
Regulation S-X as
         applicable in your response. Please include the impact of this
transaction in the pro forma
         financial statements. In addition, please provide a detailed
discussion of how you will
         account for this reorganization transaction and cite the specific
authoritative literature you
         utilized to support your accounting treatment. Please revise your MD&A
to discuss the
         expected effect of this acquisition on your future results of
operations.
Financial Statements
Note 14: Events (Unaudited) Subsequent to the Date of the Independent Auditor's
Report , page
F-33

3.       We note that on January 4, 2022 KVC effected a 20:1 forward stock
split. Please revise
         your financial statements and financial data throughout the filing to
give retroactive effect
         of the forward stock split in accordance with ASC 260-10-55-12,
505-10-S99-4 and SAB
         Topic 4C.
        We will consider qualifying your offering statement at your request. If
a participant in
your offering is required to clear its compensation arrangements with FINRA,
please have
FINRA advise us that it has no objections to the compensation arrangements
prior to
qualification.

        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff. We also remind you that, following qualification of your
Form 1-A, Rule 257
of Regulation A requires you to file periodic and current reports, including a
Form 1-K which
will be due within 120 calendar days after the end of the fiscal year covered
by the report.

       You may contact Ibolya Ignat at 202-551-3636 or Brian Cascio at
202-551-3676 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Chris Edwards at 202-551-6761 or Tim Buchmiller at 202-551-3635 with
any other
questions.



                                                                Sincerely,

                                                                Division of
Corporation Finance
                                                                Office of Life
Sciences
 Charles Wesley
Kolaboration Ventures Corporation
FirstName
February 14,   LastNameCharles
                 2022          Wesley
Comapany
Page    3      NameKolaboration Ventures Corporation
February 14, 2022 Page 3
cc:       Valerie D. Bandstra
FirstName LastName